ulcerative colitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Consistent with the TCM syndrome of liver depression and spleen deficiency; (2) Compatible with UC patients in clinical remission; (3) Age 12-75 years old gender is not limited; (4) Diagnosis of IBS in accordance with Rome IV criteria; (5) Those who signed the informed consent form and could cooperate to complete the trial (for patients aged <18 years written informed consent was also obtained from both parents).
Exclusion criteria
Exclusion criteria: (1) Patients with concomitant organic gastrointestinal abnormalities other than UC, patients with intestinal stenosis, and patients with UC who had undergone more than one previous gastrointestinal surgery; (2) Patients with significant co-morbidities (e.g., malignant tumors, unstable cardiovascular disease) were excluded; (3) Patients who have participated in other clinical trials in the last 3 months; (4) Patients with psychiatric disorders that are not well controlled; (5) Vegetarians or people with intolerance to foods such as lactose, people with severe food intolerance, or people who cannot accept the low FODMAP diet prescribed in this study due to religious beliefs, etc.; (6) People who are not on the FODMAP diet. (6) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chinese Medicine Symptom Score;IBS-SSS Symptom Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| CRP;GAD-7;Visceral Sensitivity Index;IBD-Q;Improved Mayo score;ESR;PHQ-9;fecal calprotectin; | — |
Countries
china
Contacts
The Third Affiliated Hospital of Zhejiang Chinese Medical University